Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07213167

Clinical Evaluation of Low Contrast Visual Performance and Low Light Phenomena in Patients With Various Intraocular Lens Implants

The goal of this clinical investigation is to evaluate visual acuity and contrast sensitivity in low lighting conditions using several different testing devices, and measure nighttime side effects of intraocular lens (IOL) implants after cataract surgery.

Researchers will compare the results for three different types of IOLs to see how each lens contributes to overall visual function, patient experience and satisfaction.

Participants will:

* Complete two different questionnaires about their current vision * Undergo visual testing using several different devices

Recruiting

Interested in participating?

Request Info

Key information

Age range

22 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Empire Eye and Laser Center

Bakersfield, California, 93309, United States

Location status: Recruiting

Location contact

Andrew A Kao, MD

SUB_INVESTIGATOR

Brittany M Camirand

CONTACT

[email protected]

661-301-6211

Daniel H Chang, MD

PRINCIPAL_INVESTIGATOR

Jacqueline N Albert, OD

SUB_INVESTIGATOR

Laura K Huggins, OD

SUB_INVESTIGATOR

Research Department

CONTACT

661-325-3937 ext. 203

About this study

The purpose of the study is to correlate the low contrast defocus curves, objective halometry measurement of low light photic phenomena, and patient reported dysphotopsia profiles of the various study IOLs.

The primary endpoints are low (50%) contrast defocus curve, halometry (cool white light) assessment of photic phenomena, and PRVSQv2 results.

The secondary endpoints are:

  • Visual Acuity
  • BCDVA
  • Low contrast (50%) BCDVA
  • Contrast Sensitivity
  • High contrast defocus curve
  • Halometry:
  • Light levels: low, medium, high
  • Colors: cool white, warm white, red, green
  • Characterization of glare, starbursts, and halos
  • PRO questionnaires
  • AIOLIS
  • Patient satisfaction and recommendation survey
  • Pupil size
  • YAG capsulotomy within 1 year
  • Posterior capsular opacification: pre-planned post-hoc analysis evaluating performance in patients w/wo PCO Monocular BCDVA

Participants will:

  • Complete PRVSQ v2 and AIOLIS vision questionnaires in a randomized order.
  • Undergo the following visual testing using M&S, clinical halometry, and the manifold vision meter devices:
  • Manifest refraction
  • Distance visual acuity
  • Defocus testing
  • Low contrast testing
  • Contrast sensitivity
  • Pupilometry
  • Halometry
  • Biomicroscopic slit-lamp exam
  • Intraocular pressure
  • Non-directed ocular symptoms

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Minimum 22 years of age
  • Bilateral pseudophakia, at least 3 months postoperative from IOL implantation, with one of the study IOL models in at least one eye.
  • Availability, willingness, and sufficient cognitive awareness to comply with examination procedures
  • Signed informed consent and HIPAA authorization or equivalent documentation necessary to comply with applicable privacy laws pertaining to medical treatment in the governing countries
  • Ability to understand and respond to a questionnaire in English

Exclusion criteria

  • Any clinically significant pupil abnormalities (non-reactive, fixed pupils, or abnormally shaped pupils.
  • Inability to focus or fixate for prolonged periods of time (e.g., due to strabismus, nystagmus, etc.)
  • Uncorrected distance visual acuity worse than 20/25 in either eye
  • Prior corneal refractive surgery (LASIK, LASEK, RK, PRK, etc.) or intraocular surgery. Note: Prophylactic peripheral iridotomies and peripheral laser retinal repairs that, in the opinion of the investigator will not confound study outcomes are acceptable.
  • Posterior capsular opacification with grading worse than 1+
  • Ocular findings that may, in the opinion of the investigator, affect vision and/or contrast sensitivity

Treatment and study plan

None-placebo

Other

No interventions.

Primary outcomes

  1. Low (50%) contrast defocus curve

    Time frame: Day 1

    Measured low (50%) contrast defocus curve compared between all three groups

  2. Halometry assessment of photic phenomena

    Time frame: Day 1

    Halometry assessment of halos and starbursts utilizing a cool white light with varying intensities. Comparing the measured size of the ring (deg) of each condition between all three groups.

  3. PRVSQv2 questionnaire results

    Time frame: Day 1

    PRVSQv2 questionnaire results compared between all three groups:

    Frequency and bother/severity of symptoms (scale 1 to 5, with 5 most bothersome)

Secondary outcomes

  1. Best corrected distance visual acuity (BCDVA)

    Time frame: Day 1

    Best corrected distance visual acuity (BCDVA) compared between all three groups

  2. Low contrast (50%) BCDVA

    Time frame: Day 1

    Low contrast (50%) BCDVA compared between all three groups

  3. Contrast Sensitivity

    Time frame: Day 1

    Contrast sensitivity compared between all three groups

  4. High Contrast Defocus Curve

    Time frame: Day 1

    High Contrast Defocus Curve compared between all three groups

  5. Halometry

    Time frame: Day 1

    Halometry assessment of halos and starbursts utilizing various light colors (cool white, warm white, red, yellow, and green) and intensities. Comparing the measured size of the ring (deg) of each condition between all three groups.

  6. Patient-Reported Outcome (PRO) Questionnaires

    Time frame: Day 1

    PRVSQv2 and AIOLIS vision questionnaire results compared between all three groups. Frequency and bother/severity of symptoms (scale 1 to 5, with 5 most bothersome)

  7. Pupil Size

    Time frame: Day 1

    Photopic and mesopic pupil size compared between all three study groups

  8. YAG Capsulotomies

    Time frame: Day 1

    Number of YAG capsulotomies performed within one year post-op compared between all three groups

  9. Posterior capsular opacification (PCO)

    Time frame: Day 1

    Pre-planned post-hoc analysis evaluating number of participants with and without PCO compared between all three groups

Study contacts

Contact information is provided by the study sponsor or research team.

Brittany M Camirand

CONTACT

[email protected]

661-301-6211

Daniel H Chang, MD

CONTACT

[email protected]

661-325-3937

Sponsors and collaborators

Lead sponsor

Dr. Daniel H. Chang, MD

Other

Collaborators

  • Johnson & Johnson Surgical Vision, Inc.

Registry information

Official study title

Clinical Evaluation of Low Contrast Defocus Curves, Low Light Photic Phenomena, and Dysphotopsia Profiles in Pseudophakic Patients

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Oct 8, 2025
Registry last updated
Apr 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.